JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS
 QUICK SEARCH:   [advanced]


     


First published online March 16, 2009
J Nucl Med 2009, doi:10.2967/jnumed.108.055889
© 2009 by Society of Nuclear Medicine
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnumed.108.055889v1
50/4/612    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohshima, S.
Right arrow Articles by Narula, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohshima, S.
Right arrow Articles by Narula, J.


Molecular Imaging of Matrix Metalloproteinase Expression in Atherosclerotic Plaques of Mice Deficient in Apolipoprotein E or Low-Density-Lipoprotein Receptor

Satoru Ohshima 1, Artiom Petrov 1*, Shinichiro Fujimoto 1, Jun Zhou 1, Michael Azure 2, D. Scott Edwards 2, Toyoaki Murohara 3, Navneet Narula 1, Sotirios Tsimikas 4, and Jagat Narula 1

1 Division of Cardiology, University of California, Irvine School of Medicine, Irvine, California
2 Lantheus Medical Imaging, North Billerica, Massachusetts
3 Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
4 Division of Cardiovascular Diseases, Department of Medicine, University of California, San Diego School of Medicine, La Jolla, California

* To whom correspondence should be addressed. E-mail: adpetrov{at}uci.edu.


   Abstract

Matrix metalloproteinases (MMPs) are expressed in atherosclerotic plaques and play an important role in plaque instability. Methods: Using 99mTc-labeled broad-spectrum MMP inhibitor (MPI), we performed noninvasive imaging of MMP expression with micro-SPECT/micro-CT in mice deficient in apolipoprotein E (ApoE-/-, n = 14), mice deficient in low-density-lipoprotein receptor (LDLR-/-, n = 14), and C57/BL6 mice as controls (n = 7). Seven ApoE-/- and 7 LDLR-/- received a high-cholesterol diet. After in vivo imaging, aortas were explanted, ex vivo images acquired, and the percent injected dose of MPI per gram (%ID/g) determined, followed by histologic characterization of atherosclerotic lesions. Results: MPI uptake was noninvasively visualized in atherosclerotic lesions by micro-SPECT, with confirmation by micro-CT of anatomic location and aortic calcification. %ID/g in each part of the aorta was highest in ApoE-/- that were fed a high-cholesterol diet, followed by LDLR-/- that were fed a high-cholesterol diet, ApoE-/- that were fed normal chow, and LDLR-/- that were fed normal chow. The control mice had minimal MPI uptake. A significant correlation was noted between %ID/g and % area positive for macrophages (r = 0.81, P = 0.009), MMP-2 (r = 0.65, P = 0.013), and MMP-9 (r = 0.62, P = 0.008). Conclusion: This study demonstrates the usefulness of molecular imaging for noninvasive assessment of the extent of MMP expression in various transgenic mouse models of atherosclerosis receiving a normal or hyperlipidemic diet. It is conceivable that such a strategy may be translationally developed for identification of unstable atherosclerotic plaques.

Key Words: radionuclide imaging, atherosclerosis, plaque rupture, apolipoprotein E–deficient mice, low-density-lipoprotein receptor–deficient mice







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2009 by the Society of Nuclear Medicine.